Home › Pulmonary Hypertension › District of Columbia
Pulmonary Hypertension clinical trials in District of Columbia
4 studies for Pulmonary Hypertension are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Natural History of Sickle Cell Disease
- Childrens National Health Center, Washington D.C.
RecruitingObservational study
Ages 2 to 90 · All sexes · Updated Sep 16, 2026 · NCT00081523DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Pasquerilla Healthcare Center - Georgetown University, Washington D.C.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- George Washington University Medical, Washington D.C.
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Washington Hospital Center, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.